Previous Article | Next Article ![]()
Infection and Immunity, September 1999, p. 4847-4850, Vol. 67, No. 9
Toxines et Pathogénie
Bactériennes, URA 1858, Centre National de la Recherche
Scientifique, Institut Pasteur, Paris, France
Received 25 March 1999/Returned for modification 6 May
1999/Accepted 25 May 1999
Bacillus anthracis, the causal agent of anthrax,
synthesizes two surface layer (S-layer) proteins, EA1 and Sap, which
account for 5 to 10% of total protein and are expressed in vivo. A
recombinant B. anthracis strain was constructed by
integrating into the chromosome a translational fusion harboring the
DNA fragments encoding the cell wall-targeting domain of the S-layer
protein EA1 and tetanus toxin fragment C (ToxC). This construct was
expressed under the control of the promoter of the S-layer component
gene. The hybrid protein was stably expressed on the cell surface of
the bacterium. Mice were immunized with bacilli of the corresponding
strain, and the hybrid protein elicited a humoral response to ToxC.
This immune response was sufficient to protect mice against tetanus toxin challenge. Thus, the strategy developed in this study may make it
possible to generate multivalent live veterinary vaccines, using the
S-layer protein genes as a cell surface display system.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Cell Surface-Exposed Tetanus Toxin Fragment C
Produced by Recombinant Bacillus anthracis Protects
against Tetanus Toxin
*
Corresponding author. Mailing address: Toxines et
Pathogénie Bactériennes, Institut Pasteur, 28 rue du Dr
Roux, 75724 Paris cédex 15, France. Phone: 33 1 45 68 86 54. Fax:
33 1 45 68 89 54. E-mail: smesnage{at}pasteur.fr.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»